Website intended for a NZ health professional readership
This is "plain-language" writeup of a piece of research from the Journal of the American Medical Association. Read the full article here
Using computer simulations based on real-world data from 1.2m people with symptomatic COVID-19 from 22 countries, international scientists, including an Australian, say around 6.2% of people with COVID-19 are likely to experience at least one of the three Long COVID symptom clusters three months after infection.
The three clusters are persistent fatigue with bodily pain or mood swings, cognitive problems, or ongoing respiratory problems.
Women were more likely to have Long COVID than men, the researchers say, as were patients who ended up in hospital, particularly if intensive care was required.
On average, Long COVID symptoms persisted for nine months in hospitalised patients and four months in non-hospitalised patients, although 15.1% of patients continued to experience symptoms 12 months after infection.
Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
